SYDNEY HELWIG: Open Payments
NPI 1861155434 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 52 payments from 17 companies in 2025. Trend: 2023 $750 · 2024 $1,530 · 2025 $1,262
Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $246 |
| Novartis Pharmaceuticals Corporation | 9 | $191 |
| ABBVIE INC. | 3 | $170 |
| SOBI, INC | 4 | $98 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| Daiichi Sankyo Inc. | 3 | $63 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Eisai Inc. | 2 | $41 |
Products named: LYNPARZA, ELAHERE, Vonjo, ENHERTU, LIBTAYO, SCEMBLIX, KISQALI, Nubeqa.
Industry payments across AZ — which companies pay providers there.
